http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013035773-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3cd3ea6c52ef8544c67c051a2ef489b3 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-541 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-14 |
| filingDate | 2011-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_48771660d52e93e7ce9e37a8899067b5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_85584ee3346769d85fe105c478486d1e |
| publicationDate | 2013-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2013035773-A |
| titleOfInvention | New crystals of benzothiazine dimaleate |
| abstract | An object of the present invention is to provide a novel crystal form useful for a preventive and / or therapeutic agent for allergic diseases and inflammatory diseases, which is excellent in stability and easy to handle. In an X-ray diffraction spectrum, there are characteristic peaks at diffraction angles (2θ) = 7.60, 9.28, 17.84, 22.42 and 27.48. [3- {4- (N-ethoxyethylbenzimidazol-2-ylmethyl) -1-piperazinyl} propoxy] -3,4-dihydro-2H-1,4-benzothiazin-3-one dimaleate crystal ( β-type crystal) and X-ray diffraction spectra, characteristic diffraction angles (2θ) = 17.00, 22.78, 24.14, 25.96, 26.40, and 28.54 7- [3- {4- (N-ethoxyethylbenzimidazol-2-ylmethyl) -1-piperazinyl} propoxy] -3,4-dihydro-2H-1,4-benzoe Azine-3 crystals on dimaleate salt (gamma-type crystals). [Selection figure] None |
| priorityDate | 2011-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 47.